Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nova NAD
- Development stage
- Unknown
- Lead developer
- Glam Derma
- Modality
- Small Molecules
- Administration
- Intradermal, Topical
01
Overview
Nova NAD is an aesthetic skin rejuvenation product distributed by Glamderma, primarily used as a 'skin booster' to address signs of aging and improve overall skin health. Its key active ingredient is Nicotinamide Adenine Dinucleotide (NAD+), a vital coenzyme found in all living cells that plays a central role in energy metabolism and cellular repair. In aesthetic applications, Nova NAD is intended to enhance cellular energy production (ATP), activate sirtuins (longevity-linked proteins), and support DNA repair mechanisms. These actions help to improve skin elasticity, reduce the appearance of fine lines, and protect against oxidative stress. The product is typically administered in professional settings via mesotherapy or microneedling (MTS).
- Brand names
- Nova NAD
- Other names
- NAD+ Skin Booster
02
Targets
PARP1 (Poly (adp-ribose) polymerase 1)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on Nova NAD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nova NAD.